Upsher-Smith Boosts Epilepsy Community Engagement
26 Nov 2025 //
PR NEWSWIRE
Upsher-Smith Hosts Iowa Governor for Facility Tour & Discussion
22 Jul 2025 //
CONTRACTPHARMA
2024 Excellence In Innovation Award Recognizes Pharmacy Trailblazer
11 Feb 2025 //
PR NEWSWIRE
Upsher-Smith to Feature Presentations at AES 2024 Annual Meeting
02 Dec 2024 //
PR NEWSWIRE
Upsher-Smith Wins HDA DIANA Award
19 Jun 2024 //
PR NEWSWIRE
Upsher-Smith Named as 2024 Asap Alliance Excellence Award Finalist
14 May 2024 //
PR NEWSWIRE
Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith
02 Apr 2024 //
PRESS RELEASE
Upsher-Smith Launches Methimazole Tablets, USP
29 Mar 2024 //
PR NEWSWIRE
Upsher-Smith and Naspa Announce Excellence In Innovation Award Recipients
06 Feb 2024 //
PR NEWSWIRE
Upsher-Smith Launches Pitavastatin Tablets
06 Nov 2023 //
PR NEWSWIRE
Upsher-Smith Launches Isotretinoin Capsules, Usp
24 Jul 2023 //
PR NEWSWIRE
Upsher-Smith Divests Two Migraine Products
26 Jun 2023 //
PR NEWSWIRE
Tonix Enters into Agreement to Acquire Products from Upsher-Smith Lab
26 Jun 2023 //
GLOBENEWSWIRE
Upsher-Smith Adds Dicyclomine Hydrochloride Capsules, Usp To Its Product Line
16 May 2023 //
PR NEWSWIRE
Upsher-Smith Launches Fluphenazine Hydrochloride Tablets
03 Apr 2023 //
PR NEWSWIRE
UPSHER-SMITH LAUNCHES DICYCLOMINE HYDROCHLORIDE TABLETS
06 Mar 2023 //
PR NEWSWIRE
Upsher-Smith Opens State-of-the-Art Manufacturing Facility
07 Feb 2023 //
CONTRACT PHARMA
TAKU NAKAOKA NAMED CEO OF UPSHER-SMITH LABORATORIES
12 May 2022 //
PRNEWSWIRE
Upsher-Smith Launches Carbamazepine Extended-Release Tablets, USP
16 Aug 2021 //
PR NEWSWIRE
Upsher-Smith Launches Isotretinoin Capsules
26 Jun 2021 //
PR NEWSWIRE
Upsher-Smith and Rafarm Announce Launch of Moxifloxacin Ophthalmic Solution
27 May 2021 //
PRESS RELEASE
Upsher-Smith Launches Ramelteon Tablets
15 Dec 2020 //
UPSHER-SMITH
Upsher-Smith Supports The American Headache Society`s Virtual 2020
16 Nov 2020 //
PRNEWSWIRE
Upsher-Smith and AmbioPharm Announce Partnership Agreement to Develop
07 Aug 2020 //
PRESS RELEASE
Upsher-Smith Launches Propafenone Hydrochloride Extended-Release Capsules
30 Jun 2020 //
PRNEWSWIRE
Upsher-Smith Launches Propafenone Hydrochloride Extended-Release Capsules
30 Jun 2020 //
PRESS RELEASE
Upsher-Smith Offers Help To People With Migraines During National Migraine
23 Jun 2020 //
PRNEWSWIRE
Cipher Pharmaceuticals Receives Positive Ruling on Binding Arbitration
21 Apr 2020 //
MARKETWATCH
Upsher-Smith Launches Fluvoxamine Maleate Tablets
10 Jan 2020 //
PR NEWSWIRE
Upsher-Smith Laboratories Launches Tosymra™ (sumatriptan) Nasal Spray
02 Oct 2019 //
PR NEWSWIRE
Upsher-Smith Launches Morphine Sulfate Tablets
27 Aug 2019 //
PR NEWSWIRE
Acquisition of two treatments ‘rounds out’ Upsher-Smiths migraine portfolio
02 Aug 2019 //
IN-PHARMATECHNOLOGIST
Dr Reddy`s to sell rights of 2 neurology drugs to Upsher-Smith for $110 mn
14 Jun 2019 //
BUSINESS STANDARD
Glenmark Pharma gets USFDA nod for seizure treatment drug
25 Jan 2019 //
BUSINESSWIRE
Upsher-Smith Launches Generic Version of Lomotil tablets
31 Aug 2018 //
PR NEWSWIRE
Upsher-Smith Launches Doxazosin Tablets, USP
01 May 2018 //
PR NEWSWIRE
Upsher-Smith Receives FDA Approval For Bumetanide Tablets, USP
30 Jan 2018 //
PR NEWSWIRE
Upsher-Smith Launches KLOR-CON® Powder (Potassium Chloride) For Oral Solution
28 Nov 2017 //
PR NEWSWIRE
Upsher-Smith`s Parent Company Enters Into Agreement With AstraZeneca
31 Oct 2017 //
PR NEWSWIRE
Upsher-Smith Launches Newly Designed Website For Qudexy® XR (topiramate)
22 Aug 2017 //
PR NEWSWIRE
Upsher-Smith Laboratories; Withdrawal of Approval of an ANDA for ZALEPLON
16 Aug 2017 //
FEDERAL REGISTER
Deal for U.S. Drugmaker Poised to Boost Sales for Sawai
23 May 2017 //
BLOOMBERG
Upsher-Smith Launches
08 Sep 2016 //
PR NEWSWIRE
Upsher-Smith Granted Tentative FDA Approval For Qudexy XR (topiramate)
09 Jun 2016 //
PR NEWSWIRE
Upsher-Smith Announces Start Of First In Human Clinical Trial In Oncology
16 May 2016 //
PR NEWSWIRE
Upsher-Smith, Saniona Sign Collaborate Agreement For Develope Of Novel Therap
21 Jan 2016 //
PR NEWSWIRE
Roche And Upsher-Smith Announce Agreement To Develop Novel VAP-1 Inhibitor
30 Nov 2015 //
PR NEWS WIRE
Androxy returns to market after 9-month lapse
28 Jul 2015 //
FIERCE PHARMA MANUFACTURING

Market Place
Sourcing Support